Elias Sayour, M.D., discusses the challenges of creating therapeutic cancer vaccines, advantages for mRNA vaccines and how to adapt mRNA to treat patients with cancer.

Thiago Beduschi, MD, converses UF Health’s leading liver transplant program, highlighting innovations such as MARS, an artificial liver, and NRP. He explains liver failure, patient support, and how the UF Health program became Florida’s top-ranked liver transplant center as evidenced by the Scientific Registry of Transplant Recipients (SRTR). Dr. Beduschi also outlines future advancements and the transplantation procedure.

Ashraf El-Hinnawi, MD, and Georgios Vrakas, MD, MSc, PhD, FRCS, are directors of UF Health’s pancreas transplant program, focusing on performing 15 to 20 transplants annually for selected patients, primarily those with type 1 diabetes and end-stage renal disease. The program emphasizes early referrals, robust patient management, and a multidisciplinary approach to improve outcomes and address the challenges of organ availability.

Ashraf El-Hinnawi, MD, and Georgios Vrakas, MD, MSc, PhD, FRCS, discuss advancements in kidney transplantation at UF Health, highlighting their success in increasing transplant volume and improving outcomes. They emphasize the importance of expanding living-kidney donations, managing waitlists, and exploring future research in xenotransplantation to address the organ shortage.

Dr. Maryam Rahman shares insight on the role of laser ablation in the treatment of brain tumors.

1. Review bronchiolitis pathophysiology and epidemiology.
2. Discuss the 2014 clinical guidelines on bronchiolitis.
3. Describe de-implementation strategies and projects related to bronchiolitis management.

1. Gain updated information on the current status of hemophilia gene therapy.
2. Understand the limitations of the first generation of AAV vectors currently in use.
3. Learn about the strategies being developed to mitigate those limitations.

As a result of participation in this activity, participants should be able to:
1. Understand the current HPV-related cancer epidemic: concerning trends, novel treatments, outcomes.
2. Describe the current status of smoking-related head and neck cancer: prevalence, new risks, state of the art treatments and outcomes
3. Counsel a patient on head and neck cancer prevention and outcomes of treatment.